£25.65 – £46.30
Buy GHRP-6 CJC-1295 No DAC Nasal Spray Blend
GHRP-6 CJC-1295 NO DAC Nasal Spray contains a blend of the synthetic peptides GHRP-6 and CJC-1295 without DAC (Drug Affinity Complex). GHRP-6 acts as a synthetic ghrelin agonist, interacting with the growth hormone secretagogue receptor to stimulate the release of growth hormone. CJC-1295 NO DAC is a modified version of growth hormone-releasing hormone (GHRH) that can increase plasma growth hormone levels. This particular nasal spray blend holds potential benefits in muscle building and fat loss.
GHRP-6 & CJC-1295 No DAC Blend 15ml Contains 2.5mg (CJC-1295 No DAC = 0.8mg | GHRP-6 = 1.7mg)
GHRP-6 & CJC-1295 No DAC Blend 30ml Contains 5mg (CJC-1295 No DAC = 1.6mg | GHRP-6 = 3.4mg)
479 in stock
This product is intended for research purposes only. To be used by trained professionals only.
Buy GHRP-6 CJC-1295 No DAC Blend nasal spray (available in 15ml and 30ml), an innovative way to deliver the synergistic effects of these peptides for enhanced growth hormone (GH) release. This formulation provides researchers with a user-friendly alternative to traditional injections, allowing for more consistent administration and potentially improving subject compliance in clinical and experimental settings. The nasal route enables direct absorption through mucosal membranes, allowing for rapid action while reducing some metabolic degradation seen with injections.
The blend of these two popular peptides has shown in clinical studies to enhance muscle development, improve sleep quality, boost the performance of the immune system performance and stimulate the appetite.
GHRP-6
GHRP-6, or Growth Hormone Releasing Peptide-6, is a hexapeptide that acts as a secretagogue, stimulating the pituitary gland to increase production and secretion of growth hormone [1]. It is renowned for its ability to enhance appetite by imitating ghrelin, the hormone responsible for regulating hunger and energy balance.
Additionally, this peptide facilitates the release of naturally occurring human growth hormone, leading to potential benefits such as augmented lean muscle mass and weight loss.
Explore the GHRP-6 category page to discover the range of product formulations available from Direct Peptides .
CJC-1295 no DAC
CJC-1295 NO DAC is an enhanced variant of the growth hormone-releasing hormone (GHRH). Its mechanism of action involves binding to the GHRH receptor located in the anterior pituitary gland, which in turn stimulates the release of human growth hormone [2].
The lack of DAC (Drug Affinity Complex) in this formulation results in a peptide with a shorter half-life, leading to a more rapid release of growth hormone. However, research indicates that this necessitates more frequent dosing to maintain its efficacy [3].
Visit our CJC-1295 no DAC category page for comprehensive insights into its research benefits and possible side effects. Discover a diverse range of product formats available at Direct Peptides .
In this blend, GHRP-6 effectively stimulates the pituitary gland to promote GH release, while CJC-1295 No DAC enhances this response by activating growth hormone-releasing hormone (GHRH) receptors. The combined effect aims to significantly elevate endogenous GH levels, providing a promising area for research in metabolic health, muscle recovery, and potential anti-aging therapies.
Researchers are particularly interested in its pharmacokinetic profile, dosing flexibility, and the ability to study the interactions between growth hormone modulation and clinical outcomes across different populations.
Discover our complete range of Peptide Blends available online at Direct Peptides today!
The blend GHRP-6 CJC-1295 No DAC nasal spray is a versatile formulation used in research and therapy to study growth hormone modulation and its effects on metabolism, muscle recovery, and health. Its rapid absorption makes it ideal for immediate responses, especially in post-exercise recovery.
The GHRP-6 CJC-1295 No DAC nasal spray is also crucial in clinical trials for growth hormone deficiencies and has potential applications in anti-aging therapies. Its innovative delivery method enhances user compliance and allows for flexible dosing, marking a significant advancement in peptide therapy administration and growth hormone research.
Explore our extensive collection of Peptide Nasal Sprays at Direct Peptides , specifically designed for research purposes. Select the perfect product for your research needs from our assortment of high-quality, research grade peptides.
[1] T Lei, M Buchfelder, R Fahlbusch, and E F Adams (1995) Growth hormone releasing peptide (GHRP-6) stimulates phosphatidylinositol (PI) turnover in human pituitary somatotroph cells – Journal of Molecular Endocrinology, 1995 Feb, Volume 14 (Issue 1), Pages 135-8.
[2] S L Teichman, A Neale, B Lawrence, C Gagnon, JP Castaigne, and L A Frohman (2006) Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults – Journal of Clinical Endocrinology and Metabolism, 2006 Mar, Volume 91 (Issue 3), Pages 799-805.
[3] B Bumbaca, Z Li, and D K Shah (2019) Pharmacokinetics of Protein and Peptide Conjugates – Drug Metabolism and Pharmacokinetics, Volume 34, Issue 1, February 2019, Pages 42-54.
ALL CONTENT AND PRODUCT INFORMATION AVAILABLE ON THIS WEBSITE IS FOR EDUCATIONAL PURPOSES ONLY.
DISCLAIMER: These products are intended solely as a research chemical only. This classification allows for their use only for research development and laboratory studies. The information available on our Direct Peptides website: https://direct-peptides.com is provided for educational purposes only. These products are not for human or animal use or consumption in any manner. Handling of these products should be limited to suitably qualified professionals. They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such.
BUY GHRP-6 CJC-1295 No DAC Nasal Spray ONLINE today From Direct Peptides
401 N. Mills Ave, Ste B, Orlando, FL 32803, United States
